| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Influenza A (H5) Virus RNA, Qualitative Real-Time PCR, Conjunctiva
Test Code13997
CPT Codes
87502<br><strong>This test is not available for New York patient testing.</strong>
Includes
Influenza A and Influenza H5
Preferred Specimen
1 conjunctiva swab submitted in a VCM (green-cap) tube, or equivalent (UTM) tube
Minimum Volume
1 swab
Instructions
Each Influenza A H5 specimen should be accompanied by its own separate requisition and transported in its own sealed bag. If swabbing both eyes, it is acceptable to place both swabs into one vial of VCM or equivalent. This test is not approved for observed-self collection at Quest Patient Service Centers.
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Tubes containing guanidinium isothiocyanate (GITC) • Calcium alginate swabs • Cotton swabs with wooden shaft • Amies liquid or gel transport used for bacterial cultures • Tubes with clot activator • Glass tubes • Snap-cap tubes • 3D printed swabs
Methodology
Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
FDA Status
This test is an Immediate Response test and can only be ordered by a licensed healthcare professional (for prescription use only). This test has not been reviewed or authorized by FDA. It was developed and its performance characteristics determined by Quest Diagnostics pursuant to CLIA regulations for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 1-3 days
Clinical Significance
The Influenza A (H5) Virus RNA, Qualitative Real-Time PCR is a qualitative multi-target molecular diagnostic test that aids in the detection of the Influenza A H5 virus, including H5N1, commonly known as Avian Influenza. This test does not detect Influenza B or other respiratory viruses. This test is intended to be performed on conjunctiva specimens collected from individuals suspected of infection with Influenza A H5, or who meet the Centers for Disease Control and Prevention (CDC) clinical and/or epidemiological criteria for Influenza A H5N1 testing. For details visit: https://www.cdc.gov/bird-flu/hcp/clinicians-evaluating-patients
Laboratory test results should always be considered in the context of clinical observations and epidemiological data in making a final diagnosis and patient management decisions.
Laboratory test results should always be considered in the context of clinical observations and epidemiological data in making a final diagnosis and patient management decisions.
